Cao Xiyu相关文献与解析，生知库 | 链接生命科学的每一步

Liu Song, Ding Liwen, Liu Xiong, Xing Xiaoxi, Li Jinyang, Yan Tiantian, Huang Yuli, Liu Yuan, Wang Yisa, Zhang Xia, Liu Zeming, Cao Xiyu, Meng Yuling, Shan Weixing

免疫/内分泌

发表日期：2025

文献求助收藏

Natural products targeting the immune-metabolic regulatory network in pulmonary hypertension: mechanisms, classification, and therapeutic prospects

靶向肺动脉高压免疫代谢调节网络的天然产物：机制、分类和治疗前景

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2025.1712903

Ma, Jianli; Cao, Xiyu; Yang, Xiuli; Zhu, Yi; Wang, Hualing; Liu, Yundou; Chen, Ke; Liu, Xiao; Zhang, Chuantao

Natural active botanical metabolites: targeting AMPK signaling pathway to treat metabolic dysfunction-associated fatty liver disease

天然活性植物代谢物：靶向AMPK信号通路治疗代谢功能障碍相关脂肪肝疾病

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2025.1611400

Wang, Hualing; Liu, Xinyu; Wang, Chunyi; Yu, Shishuang; Yang, Xiuli; Cao, Xiyu; Luo, Maocai; Liu, Shiwei; Zhang, Chuantao

Unlocking the link: predicting cardiovascular disease risk with a focus on airflow obstruction using machine learning

解开谜团：利用机器学习预测以气流阻塞为重点的心血管疾病风险

期刊:BMC Medical Informatics and Decision Making

影响因子:3.8

doi:10.1186/s12911-025-02885-0

Cao, Xiyu; Ma, Jianli; He, Xiaoyi; Liu, Yufei; Yang, Yang; Wang, Yaqi; Zhang, Chuantao

Global, regional, and national burden of young COPD, 1990-2021, with forecasts to 2050: a systematic analysis for the global burden of disease study 2021

1990-2021年全球、区域和国家层面青年慢性阻塞性肺病负担及至2050年预测：2021年全球疾病负担研究的系统分析

期刊:BMC Public Health

影响因子:3.6

doi:10.1186/s12889-025-21414-2

Zhu, Yi; Shen, Tao; Guo, Ruixin; Liu, Ke; Cao, Xiyu; Yang, Xiuli; Zhang, Chuantao

发表日期：2025

文献求助收藏

Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk

与非酒精性脂肪肝疾病风险相关的系统性免疫炎症生物标志物（SII、NLR、PLR 和 LMR）

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2024.1337241

Liu, Ke; Tang, Shiyun; Liu, Chenhao; Ma, Jianli; Cao, Xiyu; Yang, Xiuli; Zhu, Yi; Chen, Ke; Liu, Ya; Zhang, Chuantao; Liu, Yi

Mapping the vast landscape of multisystem complications of COVID-19: Bibliometric analysis

绘制新冠肺炎多系统并发症的广泛图谱：文献计量分析

期刊:Heliyon

影响因子:3.6

doi:10.1016/j.heliyon.2024.e30760

Zhu, Yi; Cao, Xiyu; Ying, Rongtao; Liu, Ke; Chai, Yilu; Luo, Maocai; Huang, Qingsong; Gao, Peiyang; Zhang, Chuantao

Curcumin as an antiviral agent and immune-inflammatory modulator in COVID-19: A scientometric analysis

姜黄素作为COVID-19的抗病毒剂和免疫炎症调节剂：一项科学计量学分析

期刊:Heliyon

影响因子:3.6

doi:10.1016/j.heliyon.2023.e21648

Liu, Ke; Zhu, Yi; Cao, Xiyu; Liu, Yufei; Ying, Rongtao; Huang, Qingsong; Gao, Peiyang; Zhang, Chuantao

Life's Essential 8 and cardiovascular health: Protective effects on chronic respiratory diseases

生命必需的8种营养素与心血管健康：对慢性呼吸系统疾病的保护作用

Late blight pathogen targets host Rab-G3 GTPases with an atypical GTPase-activating protein.

晚疫病病原体利用非典型的 GTPase 激活蛋白靶向宿主 Rab-G3 GTPase

Natural products targeting the immune-metabolic regulatory network in pulmonary hypertension: mechanisms, classification, and therapeutic prospects

靶向肺动脉高压免疫代谢调节网络的天然产物：机制、分类和治疗前景

Natural active botanical metabolites: targeting AMPK signaling pathway to treat metabolic dysfunction-associated fatty liver disease

天然活性植物代谢物：靶向AMPK信号通路治疗代谢功能障碍相关脂肪肝疾病

Unlocking the link: predicting cardiovascular disease risk with a focus on airflow obstruction using machine learning

解开谜团：利用机器学习预测以气流阻塞为重点的心血管疾病风险

Global, regional, and national burden of young COPD, 1990-2021, with forecasts to 2050: a systematic analysis for the global burden of disease study 2021

1990-2021年全球、区域和国家层面青年慢性阻塞性肺病负担及至2050年预测：2021年全球疾病负担研究的系统分析

Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk

与非酒精性脂肪肝疾病风险相关的系统性免疫炎症生物标志物（SII、NLR、PLR 和 LMR）

Mapping the vast landscape of multisystem complications of COVID-19: Bibliometric analysis

绘制新冠肺炎多系统并发症的广泛图谱：文献计量分析

Curcumin as an antiviral agent and immune-inflammatory modulator in COVID-19: A scientometric analysis

姜黄素作为COVID-19的抗病毒剂和免疫炎症调节剂：一项科学计量学分析